Podcasts about Genetic

We dig into how Vytelle is changing the game in cattle production. Founded in 2015, Vytelle has grown into a global force in genetic improvement, recently being ranked as the #392 fastest-growing tech company in North America by Deloitte.We begin by breaking down the basics of in-vitro fertilization (IVF) and why hormone-free IVF offers cattle producers a more natural, lower-stress, and scalable alternative to traditional embryo programs. Through Vytelle ADVANCE, producers can collect eggs weekly—even from pregnant cows—leading to shorter generation intervals and more rapid genetic gain.Next, we explore Vytelle INSIGHT, a powerful AI-powered platform that turns data into genetic decisions. Combined with Vytelle SENSE—their real-time feed intake and in-pen weight tracking system—INSIGHT helps identify the top-performing animals and guides smart, targeted mating decisions.You'll hear real-world stories from feedlots and seedstock operations using Vytelle to identify elite cattle, boost feed efficiency, and drive profitability. Whether you raise show cattle, run a dairy, or manage a cow-calf operation, Vytelle's tools deliver practical advantages that make a difference.We also discuss how these technologies are shaping the future of livestock genetics—making it more predictive, efficient, and sustainable. This is an episode for anyone looking to do more with less and take the guesswork out of herd improvement. Want Farm4Profit Merch? Custom order your favorite items today!https://farmfocused.com/farm-4profit/ Don't forget to like the podcast on all platforms and leave a review where ever you listen! Website: www.Farm4Profit.comShareable episode link: https://intro-to-farm4profit.simplecast.comEmail address: Farm4profitllc@gmail.comCall/Text: 515.207.9640Subscribe to YouTube: https://www.youtube.com/channel/UCSR8c1BrCjNDDI_Acku5XqwFollow us on TikTok: https://www.tiktok.com/@farm4profitllc Connect with us on Facebook: https://www.facebook.com/Farm4ProfitLLC/

BUFFALO, NY - July 7, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on June 17, 2025, titled “Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience.” In this study, a research team led by first author Fei Fei and corresponding author Michelle Afkhami from the City of Hope Comprehensive Cancer Center investigated a rare and aggressive type of blood cancer called blastic plasmacytoid dendritic cell neoplasm (BPDCN). Their research uncovered frequent mutations in key genes and identified CCDC50 as a potential biomarker for diagnosis and disease monitoring. These findings could help improve how this cancer is detected and treated in the future. BPDCN most often affects older adults and is known for its rapid progression and poor survival rates. The researchers performed genetic sequencing on 21 patients to better understand the disease. They found that two genes, TET2 and ASXL1, were frequently mutated in these patients and were linked to worse survival, especially in those over 65 years old. “Our study revealed that TET2 (57%) and ASXL1 (33%) were the most frequently mutated genes, followed by NRAS (29%), SRSF2 (14%), ZRSR2 (14%), and KMT2D (14%).” The study also discovered that a gene called CCDC50 was expressed at much higher levels in BPDCN samples compared to other blood cancers, such as acute myeloid leukemia and chronic monomyelocytic leukemia. This suggests that CCDC50 may help clinicians distinguish BPDCN from other similar diseases. Importantly, CCDC50 levels dropped significantly in patients whose disease went into remission, highlighting its potential as a tool for tracking disease activity over time. Researchers further observed that patients who received stem cell transplants lived longer than those who did not, reinforcing the importance of this treatment approach. However, BPDCN remains a challenging disease with an overall poor outlook, making these findings an important step toward better care. This research provides new insights into the genetic changes behind BPDCN and points to CCDC50 as a promising marker to improve diagnosis and monitor treatment success. Larger studies will be needed to confirm these results and bring these discoveries closer to use in routine medical practice. DOI - https://doi.org/10.18632/oncotarget.28742 Correspondence to - Michelle Afkhami - mafkhami@coh.org Video short - https://www.youtube.com/watch?v=wUjr3uU3onI Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28742 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, Blastic plasmacytoid dendritic cell neoplasm (BPDCN), Next-generation sequencing (NGS), CCDC50 To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Do we have another comet visiting from outside the solar system? What is Oumuamua? Is the Ring of Fire amping up in activity? Is leukaemia genetic? Does exposure to certain chemicals increase your risk of cancer? Why are early health screenings so important? How do you measure the risk of certain health treatments? Dr Chris Smith and Clarence Ford have all the answers... Like this podcast? Please help us by supporting the Naked Scientists

Do we have another comet visiting from outside the solar system? What is Oumuamua? Is the Ring of Fire amping up in activity? Is leukaemia genetic? Does exposure to certain chemicals increase your risk of cancer? Why are early health screenings so important? How do you measure the risk of certain health treatments? Dr Chris Smith and Clarence Ford have all the answers... Like this podcast? Please help us by supporting the Naked Scientists

We dive into Nucleus Genomics, a startup backed by the Founders Fund, that wants to help you evaluate, rank, and name your embryos in a pre-IVF dashboard designed for “genetic optimization.” We talk about the junk science and wild ideologies that drive these desires to treat your genes and children like assets to be managed – with the ultimate goal of creating and enforcing a society ordered by genetic hierarchies. We then wrap up by tying these biotech visions to their AI counterparts in the “Gentle Singularity.” ••• This 25-Year-Old Biotech Founder Says His Startup Can ‘Optimize' Embryos for Intelligence https://www.inc.com/ben-sherry/kian-sadeghi-says-nucleus-genomics-can-optimize-embryos-for-intelligence/91198815 ••• Controversial genetics testing startup Nucleus Genomics raises $14M Series A https://techcrunch.com/2025/01/30/controversial-genetics-testing-startup-nucleus-genomics-raises-14m-series-a/ ••• Genetics testing startup Nucleus Genomics criticized for its embryo product: ‘Makes me so nauseous' https://techcrunch.com/2025/06/06/genetics-testing-startup-nucleus-genomics-criticized-for-its-embryo-product-makes-me-so-nauseous/ ••• OpenAI wins $200m contract with US military for ‘warfighting' https://www.theguardian.com/technology/2025/jun/17/openai-military-contract-warfighting ••• This is the gentle singularity? https://www.bloodinthemachine.com/p/this-is-the-gentle-singularity ••• China shuts down AI tools during nationwide college exams https://www.theverge.com/news/682737/china-shuts-down-ai-chatbots-exam-season Standing Plugs: ••• Order Jathan's new book: https://www.ucpress.edu/book/9780520398078/the-mechanic-and-the-luddite ••• Subscribe to Ed's substack: https://substack.com/@thetechbubble ••• Subscribe to TMK on patreon for premium episodes: https://www.patreon.com/thismachinekills Hosted by Jathan Sadowski (bsky.app/profile/jathansadowski.com) and Edward Ongweso Jr. (www.x.com/bigblackjacobin). Production / Music by Jereme Brown (bsky.app/profile/jebr.bsky.social)

Have you or someone you've known experienced a pregnancy where a genetic abnormality is detected? Alex Greene is with me this morning to discuss her difficult, sensitive, and very sweet experience when she carried her baby, Iris, with Trisomy 18. She is very clear and transparent in relaying her unfolding story, or I should say, God's story, for Iris. Alex is willing to meet with anyone who would like to talk. I am setting up a Zoom call soon. You will need to contact me if you are interested. Laurie@KidStrength4Life.com 00:00 Intro01:53 Bringing Iris home02:41 Iris and her own story05:15 A part of the Greene family05:45 Alex's spiritual response09:03 Effect on relationships11:05 Grief with family and friends13:40 What Scripture was helpful? 17:17 Closing Be sure to return next week as she continues to unfold her family's story. Be sure to contact me if you are interested in meeting with Alex to answer any questions you might have. Laurie@KidStrength4Life.com Find more helpful things at https://KidStrength4Life.com Be sure to rest in the Lord this week. It is our only hope!Laurie

To what extent can maternal nutrition during pregnancy influence a child's later cognitive or behavioural development? While genetic and environmental factors are known to contribute to neurodevelopmental outcomes such as ADHD and autism, growing attention is being paid to the potential role of prenatal exposures, including dietary patterns. Yet, evidence in this area remains limited, and causality is difficult to establish. One recent study aimed to explore this question by analysing how maternal diet quality during pregnancy (specifically, adherence to a Western-style dietary pattern) related to neurodevelopmental outcomes in children assessed clinically at age 10. In this episode, Dr. David Horner discusses the findings from this prospective cohort study, the use of metabolic markers to complement dietary data, and the implications for future research into modifiable prenatal risk factors. About The Guest Dr. David Horner is a researcher in maternal nutrition and cardiometabolic health, based at the University of Copenhagen, Denmark. He is also a qualified medical doctor from Queen's University of Belfast. His research is driven by a keen interest in modifiable determinants of health, aiming to better understand and improve health outcomes. Having worked as a medical doctor for 2 years in the UK, in 2017 Dr. Horner then moved to Copenhagen, where he completed a Master's in Global Health and a PhD examining the impact of maternal dietary patterns during pregnancy on child health. Timestamps [02:47] Introduction to the study [07:08] Strengths and findings of the study [21:17] Genetic factors and gene-environment interactions [25:42] Metabolomics and potential mechanisms [30:12] Interpreting the study's findings [38:03] Future research directions [42:50] Key ideas segment (Sigma Nutrition Premium) Related Resources Subscribe to Sigma Nutrition Premium Join the Sigma email newsletter for free Enroll in the next cohort of our Applied Nutrition Literacy course See Sigma's "recommended resources" list Email: david.horner@dbac.dk Study: Horner et al., 2025 – A western dietary pattern during pregnancy is associated with neurodevelopmental disorders in childhood and adolescence David's LinkedIn post about the study (with discussion in the comments)

Genetic factors play a critical role in prostate cancer treatment planning, with both germline and somatic mutations guiding therapeutic decisions. The Association of Cancer Care Centers (ACCC) remains committed to improving prostate cancer care and has developed the Metastatic Prostate Cancer Handbook: A Guide to Optimizing Outcomes with Germline and Somatic Testing. In this episode, CANCER BUZZ speaks with Andrea Murphy, FNP-C, ACGN, CGRA, genetics nurse practitioner at Mary Bird Perkins Cancer Center and Amy D. Smith, FNP-BC, director at Meredith & Jeannie Ray Cancer Center, about the impact this handbook has had on patient care delivery, measuring success during the pilot program, and recommendations for sustaining germline and somatic mutation testing in clinical practice.   “I think a lot of people were surprised, definitely with germline testing, that all metastatic patients met the criteria [for testing]…”– Andrea (Ani) Murphy, FNP-C, ACGN, CGRA   “The other thing that the [hand]book did is [give] us a good outline on what our deficiencies were, where we wanted to go with testing...and just pretty much set it up so that it was easy for us to follow.” – Amy D. Smith, NP-BC   “Overall, I think the handbook could give anybody the guidance that they need to set up their own program.” – Amy D. Smith, NP-BC   Andrea (Ani) Murphy, FNP-C, ACGN, CGRA  Nurse Practitioner – Genetics   Mary Bird Perkins Cancer Center  Baton Rouge, LA    Amy D. Smith, FNP-BC  Director  Meredith & Jeannie Ray Cancer Center  Ivinson Memorial Hospital    Laramie, Wyoming    Resources: ACCC Metastatic Prostate Cancer Handbook: A Guide to Optimizing Outcomes with Germline and Somatic Testing  Understanding the Uptake and Challenges of Genetic Testing Guidelines for Prostate Cancer  NCCN Guidelines and Frameworks for Prostate Cancer ACCC Prostate Cancer Resources

Commentary by Dr. Jian'an Wang.

From Episode #199: “Barnyard Brainpower & Listener Mailbag: Joel Salatin on Nature-Based Learning"Access the FULL Episode HERE: https://beyondlabels.supportingcast.fm/Follow on InstagramFollow on XSubscribe on RumbleSubscribe on YouTubeFind Joel Here: www.polyfacefarms.comFind Sina Here: www.drsinamccullough.comDISCLAIMER

EPISODE NOTES:Link to Real Seed Co Blog about this topic:https://therealseedcompany.com/2025/06/morphometric-approaches-to-cannabis-evolution-and-differentiation-from-archaeological-sites/Link to peer reviewed Jouirnal on this:https://therealseedcompany.com/wp-content/uploads/2025/06/Cannabis-differentiation-and-Haimenkou.pdfBREEDERS SYNDICATE MERCH NOW AVAILABLE!https://breeders-syndicate-shop.fourthwall.comCheck out our BuyMeACoffee to Access Our Discord & Membership Plan Here:https://www.buymeacoffee.com/matthewriotBREEDERS SYNDICATE LINKS: https://linktr.ee/riotseedsFollow us on Twitch!https://www.twitch.tv/thebreederssyndicateCheck out our STRAIN DATABASE aka CODEX: https://codex.thebreederssyndicate.com/Copyright Disclaimer: The material contained herein is used under the doctrine of 'fair use' pursuant to Section 107 of the U.S. Copyright Act, allowing for limited use of copyrighted material for criticism, comment, news reporting, teaching, scholarship, and research. All rights reserved to the original copyright holders.Intro / Outro courtesy of:Sight of Wonders / Approaching the Middle East / courtesy of www.epidemicsound.com#breederssyndicate #cannaluminati #riotseeds #blueberry #strainhistory #cannabis #education #chemdog #chuckypollens #weedpodcast #bagseedtvBecome a supporter of this podcast: https://www.spreaker.com/podcast/breeders-syndicate-3-0--5630034/support.

BUFFALO, NY – June 27, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on June 17, 2025, titled “Molecular landscape of HER2-mutated non-small cell lung cancer in Northeastern Brazil: Clinical, histopathological, and genomic insights.” In this study, researchers led by first authors Cleto Dantas Nogueira from the Federal University of Ceará and Argos Pathology Laboratory and Samuel Frota from Argos Pathology Laboratory, along with corresponding author Fabio Tavora from the previously mentioned institutions and Messejana Heart and Lung Hospital, investigated how HER2 gene mutations appear in cases of non-small cell lung cancer (NSCLC) in Northeastern Brazil. The team found that HER2 mutations showed significant genetic diversity and were often associated with other cancer-related genetic changes. These findings revealed diagnostic and treatment challenges in a population that is rarely studied, emphasizing the need for expanded access to molecular testing and targeted therapies. HER2 mutations are a known factor in several cancers, including breast and gastric cancers. In lung cancer—particularly NSCLC—these mutations are less common but remain clinically significant. Most existing research on HER2-mutated lung cancer focuses on high-income countries, leaving important gaps in knowledge about underrepresented regions such as Latin America. This study helps fill that gap by analyzing 13 patients with HER2-mutated NSCLC using clinical, pathological, and genomic data. The patients ranged in age from 34 to 82 years, and more than half were women. About half had never smoked. Their tumors often displayed complex genetic profiles, including additional mutations in genes such as TP53, KRAS, and STK11. The most common HER2 mutation identified was an insertion in exon 20, a known hotspot for activating mutations. “Trastuzumab deruxtecan (T-DXd) is the first HER2-targeted agent to show clinical efficacy in HER2-mutant non-small cell lung cancer (HER2m NSCLC).” Treatment strategies among the patients varied. Only one individual received HER2-targeted therapy. Most were treated with surgery, chemotherapy, immunotherapy, or a combination of these approaches. Outcomes also differed, with some patients surviving for years and others dying within months of diagnosis. These findings reinforce the need for early diagnosis and improved access to advanced treatments, particularly in low-resource settings. The study emphasizes the value of comprehensive molecular profiling in NSCLC. Because HER2 mutations often occur alongside other genetic alterations, full genomic analysis is crucial for guiding treatment decisions. Yet, such testing is not always available. The researchers propose a tiered diagnostic approach, beginning with basic screening and expanding to more advanced tests when necessary, to enhance patient care. This study provides valuable insights into the molecular characteristics of HER2-mutated NSCLC in a Brazilian population, highlighting the complexity and clinical relevance of these alterations. Larger studies are needed to clarify the prevalence and prognostic significance of HER2 mutations, as well as their impact on treatment response and survival. This knowledge is essential for advancing effective HER2-targeted therapies. The findings also support broader implementation of international clinical guidelines in Latin America and highlight the critical need to include underrepresented populations in cancer research. DOI - https://doi.org/10.18632/oncotarget.28737 Correspondence to - Fabio Tavora - stellacpak@outlook.com Video short - https://www.youtube.com/watch?v=hr5R9iDBFFI To learn more about Oncotarget, please visit https://www.oncotarget.com. MEDIA@IMPACTJOURNALS.COM

Shangzhou Xia and Zhen Zhao discuss their paper, “Atp13a5 Marker Reveals Pericyte Specification in the Mouse Central Nervous System,” published in Vol. 44, Issue 43 of JNeurosci, with Megan Sansevere from SfN's Journals' staff. Then, Taasin Srivastava and Stephen A. Back discuss their paper, “TSG-6–Mediated Extracellular Matrix Modifications Regulate Hypoxic–Ischemic Brain Injury,” published in Vol. 44, Issue 21 of JNeurosci. Find the rest of the Spotlight collection here. With special guests: Taasin Srivastava, Stephen Back, Shangzhou Xia, and Zhen Zhao Hosted by: Megan Sansevere On Neuro Current, we delve into the stories and conversations surrounding research published in the journals of the Society for Neuroscience. Through its publications, JNeurosci, eNeuro, and the History of Neuroscience in Autobiography, SfN promotes discussion, debate, and reflection on the nature of scientific discovery, to advance the understanding of the brain and the nervous system. Find out more about SfN and connect with us on BlueSky, X, Instagram, and LinkedIn. 

In this episode of SHE MD, hosts Mary Alice Haney and Dr. Thais Aliabadi welcome Dr. Anna Lembke, a renowned expert on addiction and professor at Stanford University. Dr. Lembke discusses the concept of "Dopamine Nation" and how our modern world's constant pursuit of pleasure affects our brain chemistry and overall well-being. She delves into the neuroscience of dopamine addiction, the impact of digital media on our dopamine levels, and discusses strategies for managing addictive behaviors. The conversation covers topics ranging from social media addiction to substance abuse, offering insights into how individuals can reset their reward pathways and find balance in a world of constant stimulation.Access more information about the podcast and additional expert health tips by visiting SHE MD Podcast and Ovii. Sponsors: Cymbiotika: Go to Cymbiotikia.com/SHEMD for 20% off your order + free shipping today.Strivektin: Discover the Science Behind Great SkinOpill: Opill is birth control in your control, and you can use code SHEMD for twenty five percent off your first month of Opill at Opill.comSleepMe: Visit www.sleep.me/SHEMD to get your Chilipad at 20% off with code SHEMDNutrafol: Nutrafol is offering our listeners ten dollars off your first month's subscription and free shipping when you go to Nutrafol.com and enter promo code SHEMDDavid's Protein: David is giving my listeners an exclusive offer – buy four cartons and get the fifth free at davidprotein.com/shemdAnna Lembke's Key Takeaways:Digital Detox: Set a daily timer for digital media usage. Start with a modest reduction and gradually decrease screen time over several weeks.30-Day Reset: Choose one addictive behavior (e.g., social media, video games, unhealthy snacking) and abstain completely for 30 days. Track your progress daily to maintain accountability.Embrace Discomfort: Incorporate short bursts of activities that challenge your comfort zone, like a 10-minute cold shower or a brisk 20-minute walk. These activities help regulate dopamine levels and reduce cravings.Journaling: Dedicate 5-10 minutes each day to journaling about your digital and non-digital consumption patterns. Note any triggers or situations that lead to addictive behaviors.Family Education: Schedule a family meeting to discuss the importance of balanced digital habits and healthy coping mechanisms. Share resources and create a supportive environment for everyone to practice moderation.In This Episode: (00:00) Introduction(01:25) Dr. Anna Lembke Introduction(02:35) Modern world's addiction to digital media(05:25) What Dopamine Addiction does to your Brain?(09:48) Dopamine addiction and social media's impact to our children(18:35) Genetic factors and parental advice(22:31) Drug addiction and societal approaches(24:40) Benefits of a 30-day dopamine fast(33:27) Hormesis: Using discomfort to reset dopamine(35:27) Parkinson's, dopamine, and potential treatments(37:42) ADHD and its relationship to dopamine(38:36) Starting addiction recovery with data collectionRESOURCES:Dopamine Nation - Anna Lembke's Book: https://www.annalembke.com/GUEST BIOGRAPHY:Anna Lembke, MD is professor of psychiatry at Stanford University School of Medicine and chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. A clinician scholar, she is the author of more than a hundred peer-reviewed publications, has testified before the United States House of Representatives and Senate, and has served as an expert witness in federal and state opioid litigation. She is an internationally recognized leader in addiction medicine treatment and education.In 2016, she published Drug Dealer, MD – How Doctors Were Duped, Patients Got Hooked, and Why It's So Hard to Stop (Johns Hopkins University Press, 2016), highlighted in the New York Times as one of the top five books to read to understand the opioid epidemic (Zuger, 2018). Dr. Lembke appeared in the Netflix documentary The Social Dilemma, an unvarnished look at the impact of social media on our lives. Her book, Dopamine Nation: Finding Balance in the Age of Indulgence (Dutton/Penguin Random House, August 2021) was an instant New York Times and Los Angeles Times bestseller, has been translated into more than 35 languages, and explores how to moderate compulsive overconsumption in a dopamine-overloaded world. Her just released Dopamine Nation Workbook provides a step-by-step guide for dopamine fasting, full of interactive exercises and practical tips for finding balance.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this solo episode, Ben Pakulski unpacks the science, psychology, and strategy behind the bodybuilding diet, and why it's one of the most powerful tools for transforming your physique, performance, and mindset. This isn't just about aesthetics. It's about rewiring your brain, regaining impulse control, and mastering your relationship with food. Ben breaks down how hyper-palatable foods hijack your biology, and how a 12-week reset can unlock energy, focus, and long-term sustainability. Whether you're looking to lean out, build muscle, or just stop being controlled by cravings, this episode delivers real tools to operationalize nutrition like a high performer. Points To Watch Out For - Why hyper-palatable foods sabotage your results - The mental rewiring effects of caloric deficits - How to use food timing for impulse control - Genetic testing and personalized nutrition insights - The real reason most diets fail (and how to fix it) About Ben Ben Pakulski is the Chief Performance Officer to elite executives, successful entrepreneurs, and top athletes. With over 25 years of experience, he coaches high achievers to build the physical, psychological, and metabolic resilience required to lead at the highest level. As the creator of the Muscle Intelligence framework, Ben specializes in aligning biology and behavior to drive sustained peak performance. His mission is to redefine what's possible for people in their prime and push the boundaries of human potential.  

We have a new protein drink! Zero Fat, Zero Sugar, Zero Carb…just 23g of superior protein. Get it your protein up now-https://www.geniusshot.com/rp We only back what we use—VersaGrips are a game changer. https://www.versagripps.com/pages/drmike Want to get even more jacked? Grab the RP Hypertrophy App for your training, and maximize your gym efforts with the RP Diet Coach App to nail your nutrition.   0:17 Arnold joins the pod 2:50 Recap 5:24 Myostatin drugs 10:17 Age reversal therapy 20:23 Age reversal in older women 23:51 What happens when diseases are gone 34:44 Genetic engineering 42:36 Implications 50:30 The end of weight training 57:15 VR and no more biological humans 1:02:07 Your gains will get boosted

Genetic analysis of most cancers is becoming more commonplace, and now identification of one specific mutation called a mismatch repair may allow people to avoid surgery entirely. Johns Hopkins Kimmel Cancer Center director William Nelson explains. Nelson: What they started … Are there cancers where surgery may be entirely avoided? Elizabeth Tracey reports Read More »

Today we're reviewing Sasquatch Sunset (2024), the story of a family of Bigfoots searching in vain for more of their own kind while coming to terms with a new threat to their survival: humans. It's a beautiful, powerful film about grief, uncertainty, perseverance, hope, and poop. Lots of poop. Visit our new website! https://screensofthestoneage.com Get in touch with us: Bluesky: @sotsapodcast.bsky.social Facebook: @SotSAPodcast Letterboxd: https://letterboxd.com/sotsa/ Email: screensofthestoneage@gmail.com In this episode: Ross' yeti paper: Edwards & Barnett (2015). Himalayan ‘yeti' DNA: Polar bear or DNA degradation? A comment on ‘Genetic analysis of hair samples attributed to yeti' by Sykes et al.(2014): https://doi.org/10.1098/rspb.2014.1712 Sasquatch Birth Journal 2: https://www.youtube.com/watch?v=SVTw2w6MiFw Riley Keough – Creatures of Nature – grunt version: https://www.youtube.com/watch?v=uGlueLd7Kqo Number sense in animals: https://en.wikipedia.org/wiki/Number_sense_in_animals The Patterson Gimlin film: https://www.youtube.com/watch?v=Q60mSMmhTZU Wild chimps play with dolls: https://www.npr.org/2010/12/21/132231422/wild-chimps-may-play-dolls Sometimes a Great Notion (1971) - drowning scene: https://www.youtube.com/watch?v=6W3sZedBfIM Bigfoot behaviour: https://www.bfro.net/gdb/show_FAQ.asp?id=587 Why do chimps throw poop? https://www.livescience.com/66042-why-chimps-throw-poop.html Bowland et al. (2025). The evolutionary ecology of ethanol: https://doi.org/10.1016/j.tree.2024.09.005 Did ‘shrooms send Santa and his reindeer flying? https://www.npr.org/2010/12/24/132260025/did-shrooms-send-santa-and-his-reindeer-flying

EPISODE NOTES:Link to Real Seed Co Blog about this topic:https://therealseedcompany.com/2025/06/morphometric-approaches-to-cannabis-evolution-and-differentiation-from-archaeological-sites/Link to peer reviewed Jouirnal on this:https://therealseedcompany.com/wp-content/uploads/2025/06/Cannabis-differentiation-and-Haimenkou.pdfBREEDERS SYNDICATE MERCH NOW AVAILABLE!https://breeders-syndicate-shop.fourthwall.comCheck out our BuyMeACoffee to Access Our Discord & Membership Plan Here:https://www.buymeacoffee.com/matthewriotBREEDERS SYNDICATE LINKS: https://linktr.ee/riotseedsFollow us on Twitch!https://www.twitch.tv/thebreederssyndicateCheck out our STRAIN DATABASE aka CODEX: https://codex.thebreederssyndicate.com/Copyright Disclaimer: The material contained herein is used under the doctrine of 'fair use' pursuant to Section 107 of the U.S. Copyright Act, allowing for limited use of copyrighted material for criticism, comment, news reporting, teaching, scholarship, and research. All rights reserved to the original copyright holders.Intro / Outro courtesy of:Sight of Wonders / Approaching the Middle East / courtesy of www.epidemicsound.com#breederssyndicate #cannaluminati #riotseeds #blueberry #strainhistory #cannabis #education #chemdog #chuckypollens #weedpodcast #bagseedtvBecome a supporter of this podcast: https://www.spreaker.com/podcast/breeders-syndicate-3-0--5630034/support.

What if intimacy itself—softness, surrender, safety—was once criminalized for Black bodies, and thus encoded as a threat within the nervous system? If love during slavery was punishable by separation, humiliation, or death, then how do we today, in the echo of those lashings, trust in vulnerability without flinching?

What if intimacy itself—softness, surrender, safety—was once criminalized for Black bodies, and thus encoded as a threat within the nervous system? If love during slavery was punishable by separation, humiliation, or death, then how do we today, in the echo of those lashings, trust in vulnerability without flinching?

Renowned cardiologist and researcher, Anmol Kapoor, MD, brings an advanced, unique, scientific, and evidence-based approach to reducing cardiovascular disease and mortality. Genetic testing and personalized therapies are becoming increasingly mainstream and are important in targeting individual risks and addressing the root cause of all diseases and therapies. Your choice of testing should be safe, comprehensive, reliable, and evidence-based. Dr. Kapoor is a pioneer in developing and delivering solutions that are personalized to your quest for not only quantity of life but quality. See omnystudio.com/listener for privacy information.

For the last few years, one of my favorite parts of Tangle has been hiring young writers and giving them an opportunity to work with us. Over the years we've had a number of “interns” (nobody really does intern work here) who have made major contributions to our newsletter, gone on to work for awesome publications, or left and returned years later to work for us.Last year, our managing editor Ari Weitzman decided to formalize this experience with a six-month fellowship program. We got dozens of applications, and ended up hiring Hunter Casperson — a sharp writer and recent journalism master's graduate from California. Hunter immediately earned a reputation for thoughtful edits, speaking her mind, and stepping up to do whatever was asked of her. This month, her six months at Tangle are coming to a close. In the past, it's been simply tradition that we've let Tangle interns write a capstone piece — this year, with the process formalized, we baked it into the initial schedule of working with Hunter. The prompt is simple: You can pick any topic you want to cover, and we'll work on a well researched, long-form piece with you that we'll publish as a Friday edition. Today, we are sharing Hunter's capstone piece.It is, in my estimation, perfectly Tangle. It covers a controversial topic. It's personal. It is deeply researched. It is thoughtfully written. And most importantly, it offers fair treatment of a complicated issue. I hope you enjoy it, and I want to thank Hunter for all her contributions to Tangle — I'm excited to see what she does next! Best,Isaac SaulYou can read today's podcast⁠ ⁠⁠here⁠⁠⁠Ad-free podcasts are here!Many listeners have been asking for an ad-free version of this podcast that they could subscribe to — and we finally launched it. You can go to ReadTangle.com to sign up!You can subscribe to Tangle by clicking here or drop something in our tip jar by clicking here. Our Executive Editor and Founder is Isaac Saul. Our Executive Producer is Jon Lall.This podcast was written by: Isaac Saul & Hunter Casperson and edited and engineered by Dewey Thomas. Music for the podcast was produced by Diet 75.Our newsletter is edited by Managing Editor Ari Weitzman, Senior Editor Will Kaback, Hunter Casperson, Kendall White, Bailey Saul, and Audrey Moorehead. Hosted on Acast. See acast.com/privacy for more information.

From the archives: 8-18-23Genetic genealogy is a field that combines traditional genealogy research with modern DNA testing techniques to trace familial relationships and ancestry through genetic information. It involves analyzing an individual's DNA to uncover their genetic heritage, connect with distant relatives, and map out family trees. This approach has gained significant popularity due to advancements in DNA sequencing technology, particularly in the form of direct-to-consumer DNA testing kits.Here's how genetic genealogy works and how it's used by investigators:DNA Testing: Individuals interested in exploring their genetic heritage and family history can submit their DNA samples through services provided by companies like AncestryDNA, 23andMe, and MyHeritageDNA. These companies analyze specific segments of the submitted DNA to identify genetic markers that are common among different populations and individuals.Genetic Markers: Certain sections of the DNA, particularly those found in the Y chromosome (passed from father to son) and the mitochondrial DNA (passed from mother to all offspring), contain genetic markers that can be used to identify ancestral lineages. Autosomal DNA, which is inherited from both parents, is also examined to find matches with other individuals in the testing company's database.Matching and Comparison: Testing companies compare an individual's genetic markers with those of other users in their databases. If two individuals share a significant amount of genetic material, they are considered genetic matches. The more segments of DNA they share, the closer their relationship is likely to be.Building Family Trees: Genetic genealogy involves constructing family trees using a combination of traditional genealogical research and the information gained from DNA matches. By connecting with other users who share segments of DNA, individuals can extend their family trees and discover new branches of their lineage.Identifying Common Ancestors: As more people participate in DNA testing, the chances of finding common ancestors increase. Overlapping segments of shared DNA can help identify specific ancestors or ancestral groups that are shared among related individuals.Forensic and Investigative Applications: Genetic genealogy has also found applications in criminal investigations. Law enforcement agencies have used DNA databases to identify unknown perpetrators of crimes like murder and sexual assault. In cases where traditional investigative methods have been unsuccessful, investigators can upload DNA profiles from crime scenes to genealogy databases and identify potential relatives of the suspect based on shared genetic markers.Building Family Trees for Identification: Once potential relatives of the suspect are identified, investigators work to build family trees using genealogical records, such as birth certificates, marriage records, and obituaries. By tracing the shared ancestry of these relatives, law enforcement can narrow down the list of potential suspects to a smaller pool.Narrowing Down Suspects: Investigative genetic genealogy can help law enforcement focus on specific individuals who fit the profile of the unknown suspect based on age, location, and other relevant factors. This process has led to the successful identification and capture of suspects in several high-profile cases.In this episode we take a look at the battle of the experts that is being set up by both sides in the Bryan Kohberger trial and how it will be an uphill battle for Bryan Kohberger.(commercial at 8:44)to contact me:bobbycapucci@protonmail.comsource:How DNA Dispute Could Impact Bryan Kohberger Case (newsweek.com)

Reproductive carrier screening (RCS) should be proactively integrated into preconception care The 3-gene, Medicare-funded panel screens for cystic fibrosis (CF), spinal muscular atrophy (SMA) and fragile X syndrome (FXS) A low-risk carrier screening result is reassuring, but not absolute Partner testing is essential when a patient is identified as a carrier Fragile X results may have implications for the patient's own health Genetic counselling and clear documentation are critical components of care Healthcare professionals play a critical role in supporting patients to understand and manage RCS and its implications Host: Dr Sara Whitburn | Total Time:58 mins Experts: A/Prof Marina Berbic, Genetic Pathologist and Wendy Bruce, Executive Director Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next oneSee omnystudio.com/listener for privacy information.

David W. Johnson and Julie Murchinson revisit the collapse of 23andMe in light of the sale of the direct-to-consumer genetic testing company and the 25th anniversary of the Human Genome Project on this special episode of the 4sight Health Roundup podcast, moderated by David Burda.

People with the syndrome, caused by variants in the gene PTEN, often have autism or cancer, or both, but it depends on the genetic diversity encoded in the components of distinct cell signaling pathways, according to a new study.

Genetic testing has had some ups and downs over the past few years, with wide swaths of data sets setting a precedent for potential individualized healthcare. But, oftentimes, that data misrepresents African-descended individuals and doesn't paint the whole picture. Population geneticist Dr. Janina Jeff Ringo joins host Dr. Samantha Yammine to discuss what we can learn from genetic testing, and the gaps that sociologists are trying to fill in. Sam also explores a fascinating new study that claims to have nailed down the perfect cacio e pepe recipe and a potential solution to the growing strain on global rice yields. Link to Show Notes HERE Follow Curiosity Weekly on your favorite podcast app to get smarter with Dr. Samantha Yammine — for free! Still curious? Get science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers. Hosted on Acast. See acast.com/privacy for more information.

Ozlem Goker-Alpan, MD, Founder and President, Lysosomal & Rare Disorders Research & Treatment Center (LDRTC) and Ravi Kamath, MD, PhD, of Fairfax Radiological Consultants & Inova Health System and University of Virginia School of Medicine Fairfax, Virginia, USA discuss best practices to identify and treat bone problems associated with lysosomal disorders.This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available to other attendees.This educational program is supported by an educational grant from Takeda and Ultragenyx.To obtain credit, visit https://checkrare.com/learning/p-skeletal-involvement-in-lysosomal-disorders/quizzes/evaluation-skeletal-involvement-in-lysosomal-disorders/ FacultyOzlem Goker-Alpan, MD, Founder and President, Lysosomal & Rare Disorders Research & Treatment Center (LDRTC), Fairfax, VA Ravi Kamath, MD, PhD,Fairfax Radiological Consultants & Inova Health System and the University of Virginia School of Medicine, Fairfax, VirginiaDisclosuresAffinityCE staff, LDRTC staff, CheckRare staff, planners, and reviewers, have no relevant financial interests to disclose. All faculty disclosures are listed below and are included in the beginning of each presentation.Dr. Goker-Alpan is on the Advisory Board/Consultant for Chiesi, Takeda, Sanofi, Prevail/Lilly, Sparks Therapeutics, Uniqure, Exegenesis, Astellas, Freeline, Team Sanfilippo. She receives grants/research support from Chiesi, Sanofi, Takeda, Prevail/Lilly, Spark Therapeutics, Amicus, Freeline, Sangamo, Cyclo, Odorsia, DMT, Homology, Protaliz. She is on the speaker bureau for Sanofi, Takeda, Amicus, ChiesiDr. Kamath is on the Advisory Board for Spur Therapeutics and Intrinsic Therapeutics. He is also a consultant for Sanofi, Shire and Takeda.  Mitigation of Relevant Financial RelationshipsAffinityCE adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. A non-conflicted reviewer resolved conflicts of interest for presenting faculty with relevant financial interests through peer review of content.Learning ObjectivesDescribe the role of the orthopedic surgeon in the team approach to careDescribe best practices to monitor bone abnormalities in persons with LDsDescribe best practices to treat bone abnormalities in persons with LDsDescribe research trends in bone abnormalities in persons with LDsPhysiciansThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.AffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Physician AssistantsThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.AffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.NursesContinuing Nursing Education is provided for this program through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). This activity provides a maximum of 1 hours of continuing nursing education credit. Nurse PractitionersThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.AffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.Genetic CounselorsCategory 2 CEUThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.AffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Genetic counselors should claim only the credit commensurate with the extent of their participation in the activity.Other ProfessionalsAll other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.Commercial Support Support for this educational activity was provided by Takeda and Ultragenyx. Participation CostsThere is no cost to participate in this activity.CME InquiriesFor all CME policy-related inquiries, please contact us at ce@affinityced.com.Send customer support requests to cds_support+ldrtc@affinityced.com.

From the archives: 8-18-23Genetic genealogy is a field that combines traditional genealogy research with modern DNA testing techniques to trace familial relationships and ancestry through genetic information. It involves analyzing an individual's DNA to uncover their genetic heritage, connect with distant relatives, and map out family trees. This approach has gained significant popularity due to advancements in DNA sequencing technology, particularly in the form of direct-to-consumer DNA testing kits.Here's how genetic genealogy works and how it's used by investigators:DNA Testing: Individuals interested in exploring their genetic heritage and family history can submit their DNA samples through services provided by companies like AncestryDNA, 23andMe, and MyHeritageDNA. These companies analyze specific segments of the submitted DNA to identify genetic markers that are common among different populations and individuals.Genetic Markers: Certain sections of the DNA, particularly those found in the Y chromosome (passed from father to son) and the mitochondrial DNA (passed from mother to all offspring), contain genetic markers that can be used to identify ancestral lineages. Autosomal DNA, which is inherited from both parents, is also examined to find matches with other individuals in the testing company's database.Matching and Comparison: Testing companies compare an individual's genetic markers with those of other users in their databases. If two individuals share a significant amount of genetic material, they are considered genetic matches. The more segments of DNA they share, the closer their relationship is likely to be.Building Family Trees: Genetic genealogy involves constructing family trees using a combination of traditional genealogical research and the information gained from DNA matches. By connecting with other users who share segments of DNA, individuals can extend their family trees and discover new branches of their lineage.Identifying Common Ancestors: As more people participate in DNA testing, the chances of finding common ancestors increase. Overlapping segments of shared DNA can help identify specific ancestors or ancestral groups that are shared among related individuals.Forensic and Investigative Applications: Genetic genealogy has also found applications in criminal investigations. Law enforcement agencies have used DNA databases to identify unknown perpetrators of crimes like murder and sexual assault. In cases where traditional investigative methods have been unsuccessful, investigators can upload DNA profiles from crime scenes to genealogy databases and identify potential relatives of the suspect based on shared genetic markers.Building Family Trees for Identification: Once potential relatives of the suspect are identified, investigators work to build family trees using genealogical records, such as birth certificates, marriage records, and obituaries. By tracing the shared ancestry of these relatives, law enforcement can narrow down the list of potential suspects to a smaller pool.Narrowing Down Suspects: Investigative genetic genealogy can help law enforcement focus on specific individuals who fit the profile of the unknown suspect based on age, location, and other relevant factors. This process has led to the successful identification and capture of suspects in several high-profile cases.In this episode we take a look at the battle of the experts that is being set up by both sides in the Bryan Kohberger trial and how it will be an uphill battle for Bryan Kohberger.(commercial at 8:44)to contact me:bobbycapucci@protonmail.comsource:How DNA Dispute Could Impact Bryan Kohberger Case (newsweek.com)Become a supporter of this podcast: https://www.spreaker.com/podcast/the-moscow-murders-and-more--5852883/support.

Turns out things like bad driving are genetically influenced!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this powerful episode we sit down with Britney Marsden, also known as "The PMDD Chick," to explore the multifaceted experience of living with Premenstrual Dysphoric Disorder (PMDD). Britney opens up about her personal journey with PMDD — from misdiagnosis and confusion to self-advocacy and empowerment. She dives into the many possible root causes of PMDD, including hormonal imbalances, gut health, nutrient deficiencies, and environmental factors, emphasizing that PMDD isn't just “in your head” — it's often the result of complex physiological and psychological interactions. One key theme throughout the conversation is the role of trauma, and how unresolved emotional wounds can manifest or intensify PMDD symptoms. Britney also offers heartfelt and empowering advice to women who are struggling: from finding the right practitioners to the importance of self-compassion, community, and nervous system regulation. Her message is both hopeful and validating, reminding listeners that healing is possible — and that they're not alone.Britney Marsden, known as "The PMDD Chick," is a dedicated Women's Health Coach specializing in Premenstrual Dysphoric Disorder (PMDD). Drawing from her own experience overcoming severe PMDD, she has become a trusted source of support and knowledge for women facing this often misunderstood condition. As a qualified Women's Health Coach, Britney empowers women to identify and address factors that exacerbate PMDD symptoms. Empowering women to identify contributing factors that may exacerbate PMDD symptoms, Britney offers holistic, personalized solutions through her online PMDD programs, which provide practical strategies and insights to help women manage and alleviate their symptoms effectively.SHOW NOTES:0:39 Welcome to the show!3:18 About Britney Marsden4:28 Welcome Britney to the podcast!5:39 What is PMDD?7:12 Her diagnosis & journey through12:36 Traditional solutions for PMDD14:09 Understanding the Hormonal Cycle17:04 Genetic predispositions for PMDD18:18 BDNF, Trauma & ADD correlations19:17 MCAS, Histamine & Hidden Infections22:07 The #1 contributor to PMDD25:56 Talk therapies & ISDTP31:05 *MY ALIGN MAT*33:05 Plant Medicines & Microdosing37:04 Her root cause spinal infection40:41 POTS, MCAS & Sinus Tachycardia42:49 How she persevered & turned a corner50:25 Supplements & Biohacks for PMDD53:24 Healing gut dysbiosis55:57 Coexisting comorbidities1:00:28 Her final piece of advice1:03:40 Where to find her1:04:57 Thanks for tuning in!RESOURCES:Website: www.thepmddchick.comHer Health Confessions PodcastTikTok: https://www.tiktok.com/@thepmddchickInstagram: https://www.instagram.com/thepmddchick/Intensive Short-Term Dynamic PsychotherapyMyAlignMat - code: BIOHACKERBABESPuori - Discount code: BIOHACKERBABESOur Sponsors:* Check out Puori: https://Puori.com/BIOHACKERBABESSupport this podcast at — https://redcircle.com/biohacker-babes-podcast/donationsAdvertising Inquiries: https://redcircle.com/brands

Are your mornings setting you up for success or sabotaging your hormone health? Discover the power of morning rituals in balancing your hormones and boosting your energy levels. In this week's episode of Menopause Mastery, Dr. Betty Murray is joined by Dr. Amie "The Thyroid Fixer" a renowned expert in thyroid health and hormone balance. Together, they explore the transformative impact of morning routines on your hormonal health, especially during menopause. Learn how simple practices like early morning sunlight exposure, proper hydration, and grounding can reset your circadian rhythm and support your endocrine system. Dr. Amie shares her insights on the importance of thyroid health in your morning routine and offers practical tips to avoid common pitfalls that can disrupt your hormone balance. Whether you're navigating perimenopause, menopause, or simply looking to optimize your health, this episode provides actionable insights to help you start your day right and maintain hormonal harmony.  Links: Menrva Telemedicine: https://gethormonesnow.com/ FREE Hormone Quiz: https://bit.ly/3wNJOec Living Well Dallas: https://www.livingwelldallas.com/ Hormone Reset: https://hormonereset.net/ Betty Murray Website: https://www.bettymurray.com/ Facebook: https://www.facebook.com/BettyAMurrayCN/ Instagram: https://www.instagram.com/bettymurray_phd/ Produced by Evolved Podcasting: www.evolvedpodcasting.com   Connect with Dr. Betty Murray: Website: https://www.bettymurray.com/ Facebook: https://www.facebook.com/BettyAMurrayCN/ Instagram: https://www.instagram.com/bettymurray_phd/   Connect with Dr. Amie -Instagram: https://www.instagram.com/dramiehornaman/ -Website: https://betterlifedoctor.com/   Thank you for listening to Menopause Mastery. Empowering your health journey, one episode at a time.

Gene therapies have been in the news lately. They are being used to help individuals who have a genetic variant linked to a disorder or disease, including but not limited to: spinal muscular atrophy, carbamoyl phosphate synthetase 1 (CPS1) deficiency, diabetes and some types of cancers. What is the promise in rare genetic forms of … Continue reading "Genetic therapies in store for neurodevelopmental disorders"

Have you ever wondered if your DNA is truly fixed, or if you're destined to inherit your family's health challenges? The truth about your genetic makeup is far more extraordinary than conventional science suggests.In this illuminating conversation, William Linville takes us on a journey through the multidimensional nature of human DNA, revealing how we're composed of far more than just the genetic material passed down from our parents. Beyond the familiar double helix structure lies a vast network of 144 DNA strands representing our true creator consciousness—our divine blueprint that exists beyond physical limitation.

BREEDERS SYNDICATE MERCH NOW AVAILABLE!https://breeders-syndicate-shop.fourthwall.comCheck out our BuyMeACoffee to Access Our Discord & Membership Plan Here:https://www.buymeacoffee.com/matthewriotBREEDERS SYNDICATE LINKS: https://linktr.ee/riotseedsFollow us on Twitch!https://www.twitch.tv/thebreederssyndicateCheck out our STRAIN DATABASE aka CODEX: https://codex.thebreederssyndicate.com/Copyright Disclaimer: The material contained herein is used under the doctrine of 'fair use' pursuant to Section 107 of the U.S. Copyright Act, allowing for limited use of copyrighted material for criticism, comment, news reporting, teaching, scholarship, and research. All rights reserved to the original copyright holders.Intro / Outro courtesy of:Sight of Wonders / Approaching the Middle East / courtesy of www.epidemicsound.com#breederssyndicate #cannaluminati #riotseeds #blueberry #strainhistory #cannabis #education #chemdog #chuckypollens #weedpodcast #bagseedtvBecome a supporter of this podcast: https://www.spreaker.com/podcast/breeders-syndicate-3-0--5630034/support.

Join us for a fierce and loving conversation with Cynthia Mumtaz Anderson, Pakastani adoptee mother of two and social justice professional. Cynthia shares about her inspiring practice of Kitchen Table Politics where she has honest conversations with her children and partner about current events, how they are affecting their lives, and what they are going to do about it together. We talk about her feelings about the changing political landscape, and witnessing her sons' heartbreak while she empowers them to use their privilege to defend themselves and the people they love. We also touch on belonging, safety, citizenship, white allyship, forgiveness, and trust with special focus on Cynthia's journey of revising her relationship with performative interactions and modeling self love for her sons and her own inner child. Cynthia Anderson BioCynthia Anderson's biological name is Mumtaz which she has tattooed on the inside of her arm. She is the ammi (mother in Urdu) of two amazing boys, wife, daughter, Pakistani American adoptee, and she believes that our true worth in this life is measured by the kindness, love, and compassion we offer to others. She has worked at the University of Washington in Seattle for 19 years as an academic adviser and is active in social justice work there and in her community.Co-Hosts: Nari Baker & Robyn ParkMusic: Mike Marlatt & Paul GulledgeAudio Production: Frederico Soler FernándezArtwork: Dalhe KimListen on: iTunes & SpotifyInstagram: @laboroflovepodcastSupport via Venmo: @laboroflovepodcast

The creation of a landmark gene editing drug used to treat a baby with a rare genetic mutation which could help transform personalized medicine. Blood tests showed baby KJ had sky-high levels of ammonia, a toxic substance the body usually expels. The root cause was his genes - or more particularly a specific gene mutation. The race was on to try and treat him before his condition took a firm hold. His doctors came up with a radical solution - for the first time ever, they designed and applied a gene-editing drug in record time, specifically for him. Have we seen breakthrough in preventing genetic diseases? With Fyodor Urnov, a professor in the Molecular and Cell Biology Department at the University of California, Virginijus Šikšnys professor at the Life Science Center of Vilnius University, Waseem Qasim from the UCL Institute of Child Health in Great Ormond Street Hospital in London and Jennifer Doudna, Professor, University of California, Berkeley and founder of the Innovative Genomics Institute. Presented by Tanya Beckett. Produced by Bob Howard. Researched by Mauve Schaffer Edited by Tara McDermott.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter This is part two of a two-part mini-series on fertility and reproductive health. Paula Amato is a leading expert in female reproductive health and infertility, widely recognized for her contributions to advancing fertility treatment and research. In this episode, which follows last week's conversation on male fertility, Paula explores the biology of female fertility, including how hormonal changes regulate the menstrual cycle and ovulation, what those patterns reveal about fertility potential, and why both partners should be evaluated early in infertility workups. She discusses the role of the fallopian tubes, the causes of miscarriage, the impact of age and lifestyle on fertility, and treatment options for conditions like PCOS—including the emerging use of GLP-1 agonists. The episode also covers the evolution of IVF, advances in pre-implantation genetic testing, egg freezing, and the promise and limitations of next-generation reproductive technologies. We discuss: The finite nature of a woman's egg reserve, how it changes over time, and the basic process of ovulation and fertilization [3:00]; How hormones influence egg selection, and how and why chromosomal errors lead to most miscarriages [5:30]; The full journey of conception—from hormonal cues triggering ovulation, to fertilization, embryo development, implantation, and early pregnancy risks [16:30]; How infertility is defined and diagnosed, and the broader trends contributing to rising infertility rates [25:15]; Fallopian tube damage: how STDs and scarring impact fertility and raise ectopic pregnancy risk [31:30]; Unexplained infertility: how doctors evaluate ovulation and cycles—and why more research on women's health is needed [41:00]; The defining symptoms of polycystic ovary syndrome (PCOS), its hormonal characteristics, and its relationship with insulin resistance [44:00]; Managing PCOS without pregnancy: cycle regulation, androgen suppression, and insulin resistance treatment [46:00]; The treatment approach for women with PCOS who are trying to conceive: GLP-1 use, ovulation induction, and timing protocols [49:45]; Barriers to getting informed fertility care for PCOS: limited provider knowledge and access, insurance gaps, and next steps when ovulation treatments don't lead to pregnancy [55:45]; Fertility treatment for women with unexplained infertility, risk of multiple pregnancies with superovulation, and more [1:03:00]; Intrauterine insemination (IUI): process, success rates, and when in vitro fertilization (IVF) becomes the better option [1:07:00]; The history of in vitro fertilization (IVF), and how access and acceptance have evolved over time [1:16:45]; The step-by-step process of IVF [1:19:30]; The IVF lab process: egg retrieval, fertilization, embryo culture, and freezing [1:26:30]; Genetic testing and embryo selection in IVF: aneuploidy screening, polygenic traits, and ethical concerns [1:41:15]; Embryo transfer in IVF: timing, uterine preparation, and implantation support [1:47:30]; Egg donation in IVF: indications, donor guidelines, and other considerations [1:50:45]; How to choose the right IVF clinic [1:54:45]; Innovations in fertility on the horizon, advice about freezing eggs, and more [2:02:00]; Optimizing fertility through lifestyle: diet, stress management, sleep, exercise, and supplementation [2:07:45]; Promising areas of fertility research [2:15:45]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Dr. Shannon Manning is a Michigan State University (MSU) Foundation Associate Professor in the Department of Microbiology and Molecular Genetics. The goal of Shannon's research is to understand how pathogens (bacteria or viruses) cause disease in people. How likely a person is to get sick may be due to the different types of pathogens they are exposed to, but also genetic variation within a specific type of pathogen. Not every bacteria of a particular species is exactly identical, and some are more effective at attaching to targets and infecting hosts. When she's not working in the lab, Shannon loves spending time with her family. On the weekends, Shannon can often be found at soccer games, swim meets, and other activities cheering on her four kids. Gardening is also one of her favorite hobbies, and she has been cultivating a wonderful assortment of flowers. She earned her B.S. in biology from the University of Michigan, her M.P.H. in Hospital and Molecular Epidemiology, and her Ph.D. in Molecular Epidemiology from the University of Michigan. Afterwards, Shannon was awarded an Emerging Infectious Disease Postdoctoral Fellowship from the Center for Disease Control and Prevention. Shannon is with us today to tell us all about her journey through life and science.

What, exactly, would you need (other than the geneticly provided equipment) to make you, or someone you know, willing to have Elon's baby? Genetic advantages. The worship of sleep. 

BREEDERS SYNDICATE LINKS: https://linktr.ee/riotseedsFollow us on Twitch!https://www.twitch.tv/thebreederssyndicateCheck out our BuyMeACoffee to Access Our Discord & Membership Plan Here:https://www.buymeacoffee.com/matthewriotCheck out our STRAIN DATABASE aka CODEX: https://codex.thebreederssyndicate.com/Copyright Disclaimer: The material contained herein is used under the doctrine of 'fair use' pursuant to Section 107 of the U.S. Copyright Act, allowing for limited use of copyrighted material for criticism, comment, news reporting, teaching, scholarship, and research. All rights reserved to the original copyright holders.Intro / Outro courtesy of:Sight of Wonders / Approaching the Middle East / courtesy of www.epidemicsound.com#breederssyndicate #cannaluminati #riotseeds #blueberry #strainhistory #cannabis #education #chemdog #chuckypollens #weedpodcast #bagseedtvBecome a supporter of this podcast: https://www.spreaker.com/podcast/breeders-syndicate-3-0--5630034/support.

Dr. Lisa Kercher, St Jude Children's Research Hospital, joins Dr. Mike Brasher and Kayci Messerly for a lesson in Virology 101 and an update on the hunt for genetic changes in highly pathogenic avian influenza (HPAI). Learn about the process of reassortment, how it produces new viruses, and how these changes influence the evolving risks of HPAI. Dr. Kercher also shares stories from her mobile testing lab (BIRDWATCH), including experiences and anxious days in the field with duck researchers and banding crews and how her work is accelerating the detection of HPAI and viral changes in wild ducks. Listen in for a deeper understanding of the avian influenza virus and how hunters can continue playing a vital role.Listen now: www.ducks.org/DUPodcastSend feedback: DUPodcast@ducks.org

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter This is part one of a two-part mini-series on fertility and reproductive health, with next week's guest, Dr. Paula Amato, focusing on the female side of the equation. Paul Turek is a world-renowned expert in male fertility and reproductive health, the founder and medical director of the Turek Clinic, and host of the Talk with Turek podcast. In this episode, Paul explores the topic of male fertility, offering a detailed look at the complex and highly coordinated process of conception and the many challenges sperm face on their journey to fertilizing an egg. He shares fascinating insights into how sperm work together to navigate the female reproductive tract, how environmental factors like heat, stress, and toxins impact sperm quality, and what men can do to improve their reproductive health. Paul also dispels common myths about testosterone replacement therapy and its effects on fertility, providing strategies for preserving fertility while on TRT. The episode also highlights cutting-edge advances in reproductive medicine, from genetic testing and sperm sorting to emerging treatments for infertility. We discuss: The incredibly complex and hostile journey sperm must take to fertilize an egg [3:00]; How sperm are made: meiosis, genetic variation, and the continuous renewal influenced by environmental factors [9:00]; The built-in filter that weeds out genetically abnormal sperm [14:45]; How sperm are finalized in form and function: tail formation, energy storage, and chemical sensing abilities [18:30]; How to optimize conception through the timing of sex, ejaculation frequency, and understanding the sperm lifecycle [26:30]; Male infertility and Paul's diagnostic approach: detailed history, a physical exam, and identifying red flags [33:30]; Viral infections that can affect the testes and potentially lead to sterility [40:30]; Semen analysis: morphology, motility, and hormonal clues to male fertility [45:45]; Effects of medication, microplastics, stress, and exercise on fertility [57:15]; Testosterone replacement therapy (TRT) and male fertility [1:06:00]; Restoring fertility after prolonged use of exogenous testosterone [1:25:00]; Effects of heat and cold exposure on fertility and sperm quality [1:36:00]; How different levels of exercise—especially cycling—affect male fertility [1:41:45]; How alcohol, marijuana, and nicotine affect male fertility [1:46:00]; Why type 2 diabetes is a risk factor for male infertility [1:50:00]; How varicoceles—a common cause of male infertility—are diagnosed and treated [1:51:15]; Genetic factors that affect fertility [1:54:00]; The impact of lifestyle and environmental exposures on fertility [1:56:30]; The evidence (or lack thereof) behind stem cell and PRP therapies for male infertility, and how lifestyle and non-invasive interventions often lead to successful conception [2:00:30]; Considerations for sperm banking, and how paternal age impacts fertility planning and offspring health [2:05:00]; Semen quality as a biomarker: linking male fertility, longevity, and preventative health through Medicine 3.0 and epigenetics [2:14:45]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

➡️ Like The Podcast? Leave A Rating: https://ratethispodcast.com/successstory In this “Lessons” episode, genetic health expert Kashif Khan reveals how your DNA is not a life sentence but a user manual—showing how brain inflammation, not just genetics, triggers diseases like Alzheimer's, why most chronic illnesses are caused by lifestyle and environmental factors, and how personalized nutrition, stress management, and subtle daily tweaks can dramatically extend both your healthspan and lifespan. Learn how to reverse-engineer disease by identifying root causes like leaky gut, toxic air, and hormone imbalances—and discover how your body is biologically built to thrive to 120 if you treat it right.➡️ Show Linkshttps://successstorypodcast.com YouTube: https://youtu.be/rXWMFjXK8Sg Apple: https://podcasts.apple.com/us/podcast/kashif-khan-founder-of-the-dna-company-hack/id1484783544 Spotify: https://open.spotify.com/episode/14lPyhhZRkgy7K5lZRINEm ➡️ Watch the Podcast on YouTubehttps://www.youtube.com/c/scottdclary See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.